Home
>
National Drug Code (NDC)
>
Horizant
Horizant - 53451-0102-1 - (gabapentin enacarbil)
Drug Information of Horizant
| Product NDC: | 53451-0102 |
| Proprietary Name: | Horizant |
| Non Proprietary Name: | gabapentin enacarbil |
| Active Ingredient(s): | 300 mg/1 & nbsp; gabapentin enacarbil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Horizant
| Product NDC: | 53451-0102 |
| Labeler Name: | XenoPort Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022399 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130501 |
Package Information of Horizant
| Package NDC: | 53451-0102-1 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0102-1) |
NDC Information of Horizant
| NDC Code | 53451-0102-1 |
| Proprietary Name | Horizant |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0102-1) |
| Product NDC | 53451-0102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | gabapentin enacarbil |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130501 |
| Marketing Category Name | NDA |
| Labeler Name | XenoPort Inc. |
| Substance Name | GABAPENTIN ENACARBIL |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
